MARLBOROUGH, Mass., May 15, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in Bernstein's 35th Annual Strategic Decisions Conference on Wednesday, May 29, 2019 in New York City.
Mike Mahoney, chairman and chief executive officer, and Susie Lisa, vice president, Investor Relations, will participate in a 50-minute question-and-answer session with the host analyst beginning at approximately 8:00 a.m. EDT. A live webcast of the question-and-answer session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com.
A replay of the webcast will be accessible at investors.bostonscientific.com beginning approximately one hour following the completion of the event.
About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.
SOURCE Boston Scientific Corporation